Share Steve Rosenberg, Chief Executive Officer, uMotif, discusses the challenges sites face with eCOA, eConsent, ePRO platforms and the support needed to reduce technical burdens. Watch the interview with Applied Clinical Trials here. Previous: Best Practice Recommendations and Considerations for Designing and Electronically Implementing Event-Driven Diaries in Clinical Trials Next: Retention in Paediatric Rare Disease Clinical Trials